WEEKLY TOP 5
YOUR WEEKLY UPDATES FROM SHEBA MEDICAL CENTER
Gain valuable information about healthcare issues that affect you and your community
A Whirlwind of Successful Global Events
From Toronto, Canada to New York and Los Angeles, USA, Sheba Medical Center highlighted a series of successful events during the past week, which underscored our superior clinical research to combat a variety of maladies, as well as our headline-making humanitarian outreach in the Ukraine and our on-going efforts in Bahrain, UAE and Morocco.
This week, Sheba began a three-day ‘Future of Health Summit’, where dozens of CEO’s from some of the world’s top hospitals will engage in a series of meetings to discuss a range of hot button issues that will impact the future of global healthcare over the next decade.
The Summit will also feature appearances by numerous Ambassadors from around the globe and officials from President Biden’s administration.
RADIOTHERAPY FIGHTS CANCER PAIN
PROF. ZIMLICHMAN PROFILED IN AUSSIE MEDIA
PROF. MICHAL BEERI ON ALZHEIMER MEDS
TACKLING THYROID EYE DISEASE
PRES. BIDEN APPOINTS DR. STEPHEN KLASKO TO KEY EDUCATIONAL BOARD
More Posts
Sheba Medical Center Join General Catalyst’s Health Assurance Ecosystem to Advance Innovative Medical Solutions
General Catalyst is a leading US-based venture capital firm specializing in early-stage and growth investments across various industries, including technology, healthcare, and consumer goods. Known for its strategic approach and deep industry knowledge, General Catalyst not only provides financial support to entrepreneurs but also offers valuable guidance and resources to help them navigate the complex challenges of building and expanding their businesses.
Revolutionizing Diagnostic Medicine: Sheba Partners with Aidoc for Early Intracerebral Hemorrhages Detection
A pioneer in the application of AI in clinical settings, Sheba has played a central role in the development of numerous solutions that are now used across the globe. This includes Aidoc, which was founded at Sheba and now provides advanced AI decision-support tools to many of the world’s leading medical centers.
Sheba and Vidac Pharma Partner to Overcome the Warburg Effect
CAR T-cell therapy is a revolutionary blood cancer treatment that involves extracting and genetically engineering a patient’s T-cells to produce chimeric antigen receptors, or CARs, that facilitate the targeting and elimination of malignant cells.
